(Q38402754)

2 September 2017

title

Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma (English)

1 reference

2 September 2017

5

Kari Syrjänen

1 reference

2 September 2017

Adam Elzagheid

1

1 reference

2 September 2017

Abdelbaset Buhmeida

2

1 reference

2 September 2017

Matti Laato

3

1 reference

2 September 2017

Omran El-Faitori

4

1 reference

2 September 2017

Yrjö Collan

6

1 reference

2 September 2017

Seppo Pyrhönen

7

1 reference

2 September 2017

publication date

23 January 2012

1 reference

Acta Pathologica et Microbiologica Scandinavica

2 September 2017

published in

1 reference

2 September 2017

volume

120

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

539-548

1 reference

Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Biomarker-based prediction of response to therapy for colorectal cancer: current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Biological and clinical markers in colorectal cancer: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Molecular predictive and prognostic markers in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Noninvasive molecular biomarkers for the detection of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Involvement of members of the cadherin superfamily in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Cell-adhesion molecule uvomorulin is localized in the intermediate junctions of adult intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Cadherins as Modulators of Cellular Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Molecular components of the adherens junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Defective E-cadherin/catenin complexes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Cadherins in cancer: implications for invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Surgical therapy for colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Follow-up after curative resection of colorectal cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Correlation of nuclear morphometry and DNA ploidy in rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Colorectal cancer proteomics, molecular characterization and biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Adjuvant chemotherapy in colon cancer: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

DNA methylation markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

The cell-cell adhesion molecule E-cadherin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0463.2011.02863.X

10.1111/J.1600-0463.2011.02863.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference